Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 306.00
Bid: 305.50
Ask: 306.50
Change: 3.50 (1.16%)
Spread: 1.00 (0.327%)
Open: 300.00
High: 306.50
Low: 300.00
Prev. Close: 302.50
MGAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Trading and Cyber Security Incident

7 Feb 2023 07:00

RNS Number : 0905P
Morgan Advanced Materials PLC
07 February 2023
 

Press Release

Morgan Advanced Materials plc

7 February 2023

 

Update on Trading and Cyber Security Incident

Morgan Advanced Materials plc (the "Group") provides an update on trading results for 2022 and on the cyber security incident previously announced on 10 January 2023.

Key points

- FY2022 trading performance expected to be slightly ahead of market expectations

- In response to the cyber security incident:

o All manufacturing sites are operational

o Resolution of systems issues continues at pace

o H1 2023 demand remains strong, but production inefficiencies expected to impact FY2023 adjusted operating profit by 10% to 15%

o FY2022 preliminary results now expected to be announced by end of April 2023

Trading Update

Revenue growth remained robust in the final two months of the year with revenue expected to be around £1.1bn, representing growth of 16% or 11% at constant currency. FY2022 adjusted operating profit is expected to be slightly above the top-end of the range of analysts' forecasts¹. Net debt at the year end was £148.6m, in line with market expectations and 0.8x EBITDA.

Cyber Security Incident

As announced on 10 January 2023, the Company is managing the consequences of a cyber security incident having detected unauthorised activity on its network. Immediate steps were taken to contain the incident, launch incident response plans, engage specialist support services and embark on restoring systems.

All manufacturing sites are operational, although some continue to use manual transaction processes as work continues to restore their systems. A small number of systems have proven irrecoverable and so we are accelerating the implementation of a new cloud-based ERP solution at the affected sites. 

All appropriate regulatory authorities have been informed of the incident.

Exceptional costs associated with the incident could amount to approximately £8m to £12m, comprising specialist professional fees, as well as costs associated with recovering a number of systems across the Morgan Group.

It remains challenging to estimate precisely the extent of any impact on our H1 2023 trading. During January, a number of sites experienced a delay in restarting production and shipping due to the cyber security incident. Whilst demand has remained strong during January, we are experiencing production inefficiency during the recovery period which, based on current estimates, could lead to adjusted operating profit for FY2023 being approximately 10% to 15% below our previous expectations.

The Group has a strong balance sheet and does not expect the incident to have a material long term impact.

 ¹ Company compiled consensus for adjusted operating profit is £139.2m, with a range of £133.5m to £145.0m.

2022 Preliminary results timing

As a result of the systems impact from the cyber security incident, we are working with our auditors to reschedule the audit of the 2022 preliminary results and currently expect to be able to issue them by the end of April 2023.

Revised dates for our FY2022 preliminary results and our 2023 Annual General Meeting will be published in due course.

 

This announcement contains inside information. The person responsible for arranging the release of this announcement is Richard Armitage, CFO. The company's LEI is I4K14LL95N2PHDL7EG85.

 

For further enquiries:

Pete Raby, CEO Morgan Advanced Materials plc 01753 837000

Richard Armitage, CFO

Nina Coad Brunswick 0207 404 5959

 

All financial information included in this announcement is sourced from unaudited management accounts and excludes any specific adjusting items. This announcement contains certain forward-looking statements that are based on management's current expectations or beliefs as well as assumptions about future events. These are subject to risk factors associated with, amongst other things, the economic and business circumstances occurring from time to time in the countries and sectors in which the group operates. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a wide range of variables which could cause actual results, and the group's plans and objectives, to differ materially from those currently anticipated or implied in the forward-looking statements. Investors should not place undue reliance on any such statements.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCXQLLBXLLFBBQ
Date   Source Headline
24th Apr 20247:00 amRNSCapital Markets Update
5th Apr 202412:55 pmRNSAnnual Financial Report
4th Apr 20241:16 pmRNSDirector/PDMR Shareholding
27th Mar 20244:52 pmRNSDirector/PDMR Shareholding
27th Mar 20244:50 pmRNSDirector/PDMR Shareholding
27th Mar 20244:49 pmRNSDirector/PDMR Shareholding
27th Mar 20244:48 pmRNSDirector/PDMR Shareholding
14th Mar 20249:42 amRNSDirector/PDMR Shareholding
14th Mar 20249:41 amRNSDirector/PDMR Shareholding
13th Mar 202412:10 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSMorgan Advanced Materials Full Year 2023 Results
27th Dec 20237:00 amRNSDirector/PDMR Shareholding
19th Dec 20231:56 pmRNSDirector/PDMR Shareholding
18th Dec 20234:25 pmRNSBlock listing Interim Review
22nd Nov 202310:07 amRNSDirector/PDMR Shareholding
9th Nov 20237:00 amRNSQ3 Trading Update
9th Oct 20234:43 pmRNSDirector/PDMR Shareholding
26th Sep 202312:24 pmRNSDirector/PDMR Shareholding
16th Aug 202311:27 amRNSDirector/PDMR Shareholding
7th Aug 20235:24 pmRNSDirector/PDMR Shareholding
4th Aug 20237:00 amRNSHalf-Year Results for Period Ended 30 June 2023
13th Jul 20234:49 pmRNSDirector/PDMR Shareholding
5th Jul 20234:51 pmRNSDirector/PDMR Shareholding
29th Jun 20235:06 pmRNSResult of AGM
29th Jun 20237:00 amRNSH1 Trading Update
22nd Jun 202311:50 amRNSBlock listing Interim Review
31st May 20233:52 pmRNSDirector/PDMR Shareholding
26th May 20233:28 pmRNSNotice of Annual General Meeting 2023
24th May 20233:59 pmRNSDirector/PDMR Shareholding
11th May 202312:06 pmRNSDirector/PDMR Shareholding
11th May 202312:01 pmRNSDirector/PDMR Shareholding
11th May 202311:59 amRNSDirector/PDMR Shareholding
9th May 20235:59 pmRNSDirector/PDMR Shareholding
4th May 20235:28 pmRNSAnnual Report & Accounts 2022
3rd May 20235:38 pmRNSDirector/PDMR Shareholding
3rd May 20235:28 pmRNSDirector/PDMR Shareholding
28th Apr 20235:45 pmRNSInformation required by DTR 4.1
28th Apr 20237:00 amRNSFull-year results for the period ended 31 Dec 2022
13th Apr 20237:00 amRNSNotification of Full-Year Results
7th Feb 20237:00 amRNSUpdate on Trading and Cyber Security Incident
18th Jan 20237:00 amRNSAppointment of Chair Designate
10th Jan 20237:00 amRNSNotice of Cyber Security Incident
22nd Dec 202211:01 amRNSBlock listing Interim Review
16th Dec 20224:44 pmRNSHolding(s) in Company
6th Dec 20227:00 amRNSAccelerated Pension Contribution
6th Dec 20227:00 amRNSCapital Markets Event
23rd Nov 202210:01 amRNSDirector/PDMR Shareholding
15th Nov 20225:06 pmRNSDirector/PDMR Shareholding
10th Nov 20228:03 amRNSDirector Declaration
4th Nov 20227:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.